BioCentury

12:38 AM GMT, Sep 25, 2012
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Company News

Valeant acquires Visudyne from QLT

Valeant Pharmaceuticals International Inc. (TSX:VRX; NYSE:VRX) acquired rights to ophthalmic product Visudyne verteporfin from

Read the full 146 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.